Morgan Stanley Elevance Health, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Elevance Health, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,452,767 shares of ELV stock, worth $1.26 Billion. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,452,767

Previous 3,226,999 7.0%

Holding current value

$1.26 Billion

Previous $1.75 Billion 2.68%

% of portfolio

0.13%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$500.12 - $562.29 $113 Million - $127 Million	225,768 Added 7.0%	3,452,767 $1.8 Billion
Q2 2024 Oct 17, 2024	BUY	$497.49 - $547.8 $136 Million - $150 Million	273,155 Added 9.25%	3,226,999 $1.75 Billion
Q2 2024 Aug 14, 2024	BUY	$497.49 - $547.8 $136 Million - $150 Million	273,155 Added 9.25%	3,226,999 $1.75 Billion
Q1 2024 Oct 17, 2024	SELL	$464.61 - $519.96 $127 Million - $142 Million	-273,155 Reduced 8.46%	2,953,844 $1.53 Billion
Q1 2024 Aug 16, 2024	BUY	$464.61 - $519.96 $23.3 Million - $26.1 Million	50,159 Added 1.73%	2,953,844 $1.53 Billion
Q1 2024 May 15, 2024	BUY	$464.61 - $519.96 $23.3 Million - $26.1 Million	50,159 Added 1.73%	2,953,844 $1.53 Billion
Q4 2023 Aug 16, 2024	SELL	$433.51 - $488.06 $140 Million - $158 Million	-323,314 Reduced 10.02%	2,903,685 $1.37 Billion
Q4 2023 Feb 13, 2024	BUY	$433.51 - $488.06 $51.6 Million - $58.1 Million	118,971 Added 4.27%	2,903,685 $1.37 Billion
Q3 2023 Nov 15, 2023	BUY	$414.13 - $475.93 $19.2 Million - $22 Million	46,322 Added 1.69%	2,784,714 $1.21 Billion
Q2 2023 Aug 14, 2023	SELL	$436.33 - $496.2 $10.5 Million - $11.9 Million	-24,049 Reduced 0.87%	2,738,392 $1.22 Billion
Q1 2023 May 15, 2023	SELL	$446.3 - $502.2 $80.7 Million - $90.8 Million	-180,764 Reduced 6.14%	2,762,441 $1.27 Billion
Q4 2022 Feb 14, 2023	BUY	$465.23 - $546.77 $216 Million - $254 Million	465,102 Added 18.77%	2,943,205 $1.51 Billion
Q3 2022 Nov 14, 2022	BUY	$445.98 - $507.0 $8.07 Million - $9.17 Million	18,094 Added 0.74%	2,478,103 $1.13 Billion
Q2 2022 Oct 27, 2022	BUY	$444.32 - $529.84 $436 Million - $519 Million	980,223 Added 66.24%	2,460,009 $1.19 Billion
Q2 2022 Aug 15, 2022	BUY	$444.32 - $529.84 $436 Million - $519 Million	980,223 Added 66.24%	2,460,009 $1.19 Billion
Q1 2022 Oct 27, 2022	SELL	$428.44 - $502.48 $420 Million - $493 Million	-980,223 Reduced 39.85%	1,479,786 $727 Million
Q1 2022 May 13, 2022	SELL	$428.44 - $502.48 $94.8 Million - $111 Million	-221,355 Reduced 13.01%	1,479,786 $727 Million
Q4 2021 Feb 14, 2022	BUY	$370.08 - $467.67 $18.9 Million - $23.9 Million	51,202 Added 3.1%	1,701,141 $789 Million
Q3 2021 Nov 15, 2021	BUY	$357.51 - $398.13 $590 Million - $657 Million	1,649,939 New	1,649,939 $615 Million

Others Institutions Holding ELV

# of Institutions

1,861

Shares Held

197M

Call Options Held

1.03M

Put Options Held

1.24M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $87.8B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account